U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Successfully Navigating the USPTO and FDA - 09/08/2022
  1. News & Events for Human Drugs

Virtual | Virtual

Event Title
Successfully Navigating the USPTO and FDA
September 8, 2022

Date:
September 8, 2022

About this Virtual Meeting:

FDA, the U.S. Patent and Trademark Office (USPTO), the Silicon Valley PTO, and Biocom California will hold a free virtual meeting in which participants can hear about the intricacies that biotech and medtech independent inventors and startups face when seeking regulatory approval from the FDA and securing intellectual property rights from the USPTO. Speakers from government and industry will offer their views on current issues in this area and discuss best practices for navigating FDA and USPTO processes.

Speakers:

  • Brandon Fetterolf, USPTO - Director (acting), TC 1600 Biotechnology and Organic Chemistry
  • Jonathan Teixeira Moffat, USPTO - Director, TC 3700 Medical Devices and Processes
  • Kevin Bugin, Ph.D., FDA - Deputy Director for Operations, Center for Drug Evaluation and Research /Office of New Drugs
  • Barbara Zimmerman, FDA - Deputy Office Director, Center for Devices and Radiological Health
  • Tom Cowan, Knobbe Martens - Partner

Registration:

Register here

 

 

Back to Top